John Barr now in charge

[Anonymous]

John Barr? Why? It would make more since to put surgical under the new head of global Pharma and base everything in California that is surgical/ophthalmology related. Same old organization will lead to the same old results and a new replacement of the VP in a year when the organization flaws fail B+L once again.

 

[Anonymous]

John Barr? Why? It would make more since to put surgical under the new head of global Pharma and base everything in California that is surgical/ophthalmology related. Same old organization will lead to the same old results and a new replacement of the VP in a year when the organization flaws fail B+L once again.

You are right that this is a flawed organization. Too many facilities in Pharma and Surgical. If Pharma and Surgical were in one location this would be a hot IPO. Ten different facilities spread all around the US is just stupid. Reg in NJ, D&R rochester, Manufacturing Tampa, new acquisition California.

Most would look at the organizational charts for Pharma and Surgical and walk away as it would take too much work to integrate the various locations into their business. Most expect that the private equity firm would have integrated and consolidated the company prior to sale.

Now is the time for full company reorganization that makes sense to people internal in the organization and to potential investors looking in.

 

[Anonymous]

As an outsider looking in but from the ophthalmic industry, WHY would B&L bring in someone with NO ophthalmic experience?

Not the first time B&L has done this. In fact under this new management team they seem intent on bringing in people they know from other companies with no real ophthalmic experience. Jerry O, Flemming, Saunders, Perry, Phil. None of them had any real ophthalmic experience, except perry who helped destroy novartis ophthalmics in retinal.

I bet if you look close enough, someone knew this guy from a previous job.

Head honchos at the company should be people that grew up in the industry and have many key contacts with the top surgical centers and docs across the country.

Long standing relationships in Ophthalmics is what drives sales. Alcon & allergan get it. That's why they have the lion's share of the business.

Why would you not recruit a top Alcon or Allergan exec to head surgical...
Just makes no sense. This guy will not drive new sales growth, because the sales team will still not be able to penetrate the alcon allergan market share.

 

[Anonymous]

As an outsider looking in but from the ophthalmic industry, WHY would B&L bring in someone with NO ophthalmic experience?

Not the first time B&L has done this. In fact under this new management team they seem intent on bringing in people they know from other companies with no real ophthalmic experience. Jerry O, Flemming, Saunders, Perry, Phil. None of them had any real ophthalmic experience, except perry who helped destroy novartis ophthalmics in retinal.

I bet if you look close enough, someone knew this guy from a previous job.

Head honchos at the company should be people that grew up in the industry and have many key contacts with the top surgical centers and docs across the country.

Long standing relationships in Ophthalmics is what drives sales. Alcon & allergan get it. That's why they have the lion's share of the business.

Why would you not recruit a top Alcon or Allergan exec to head surgical...
Just makes no sense. This guy will not drive new sales growth, because the sales team will still not be able to penetrate the alcon allergan market share.

B&L is going to flip this thing quickly. They could have hired Micky Mouse as the CEO and it will not make much of a difference. It will be sold by this time next year.